Karnataka has held discussions with senior leaders of Takeda Pharmaceutical on expanding the company’s Global Capability Centre operations in Bengaluru. The talks point to continued interest from major international healthcare companies in growing their presence in the state.
According to the details available, the discussions focused on digital transformation, research and product development. These areas are central to how global pharmaceutical companies use capability centres, combining technology, data and specialized talent to support wider business and scientific work.
The state government also used the meeting to underline Karnataka’s strengths as an investment and innovation destination. Bengaluru has become a key base for global capability centres across sectors, and the latest talks with Takeda reflect how life sciences and technology are increasingly overlapping in the city.
While no detailed outcome was outlined in the available report, the engagement suggests Karnataka is seeking deeper partnerships with Takeda beyond routine operations. Any expansion of the company’s Bengaluru GCC would further reinforce the city’s role in digital, research and product-focused work for multinational businesses.
